Characterizing the treatment patterns, medication burden, and patient demographics of older adults with major depressive disorder treated with antidepressants with or without selected comorbidities-Reference-Cited by-同舟云学术

Characterizing the treatment patterns, medication burden, and patient demographics of older adults with major depressive disorder treated with antidepressants with or without selected comorbidities

Published:2024-05-16 Issue:6 Volume:40 Page:1027-1038
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Gannu Laxmi¹,Devine Francesca²^ORCID,Popadic Lyuba²^ORCID,Lal Sagar²,Witte Michael³^ORCID,Potter Marci⁴,Hass Steve¹^ORCID

Affiliation:

1. HEOR Real-World Evidence (RWE), Sage Therapeutics, Inc., Cambridge, MA, USA

2. HEOR, Komodo Health, Inc., San Francisco, CA, USA

3. Global Medical Affairs, Sage Therapeutics, Inc., Cambridge, MA, USA

4. Neuropsychiatry, US Medical, Biogen Inc, Cambridge, MA, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2348603

Reference45 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Major depressive disorder

3. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

4. Depression Is the Leading Cause of Disability Around the World

5. Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2022.